Acetohydroxamic acid | B3286

Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. It inhibits the growth of struvite crystals produced by P. mirabilis in artificial urine and the growth of H. pylori in vitro (MICs = 200 and 400 mg/L for various isolates of H. pylori). Chronic AHA administration in dogs dose-dependently reduces urine urease activity, pH, and crystalluria and inhibits growth of bladder stones

Acetohydroxamic acid is a potent inhibitor of bacterial urease activity and reduces urinary ammonia levels. It inhibits the growth of struvite crystals produced by P. mirabilis in artificial urine and the growth of H. pylori in vitro (MICs = 200 and 400 mg/L for various isolates of H. pylori). Chronic AHA administration in dogs dose-dependently reduces urine urease activity, pH, and crystalluria and inhibits growth of bladder stones

B3286 | Acetohydroxamic acid DataSheet

Alternate Name/Synonyms: NSC 408425 NSC 176136 NSC 5073 AHA

Appearance: White to yellow solid

Formulation:

CAS Number: 546-88-3

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂H₅NO₂

Molecular Weight: 75.07

Cell-Permeable?: True

Purity: ≥98%

Solubilities: >15 mg/ml DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: An irreversible urease inhibitor

MDL Number: MFCD00009994

PubChem CID: 1990

SMILES: ONC(C)=O

InChi: InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)

InChi Key: RRUDCFGSUDOHDG-UHFFFAOYSA-N